glp 1 hfpef GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and on SGLT2 Inhibitors Malnutrition and Sarcopenia as Reasons
Description
GLP-1 medications are often used in patients with chronic kidney disease, and caution is warranted
Treatment duration should be determined in consultation with your healthcare provider based on individual response and goals
Compounded GLP-1based treatment plans are commonly incorporated into physician-guided weight loss programs for patients seeking structured support and ongoing care with appetite awareness and portion control
Get doctor approval Always consult with your healthcare provider before considering GLP-1 medications
